Apollomics (APLM) CEO Chen Hung-Wen details direct, indirect shares and RSUs

Rhea-AI Filing Summary

Apollomics Inc. director and CEO Chen Hung-Wen reported his initial holdings. He holds 20,000 restricted stock units, each representing one Class A Ordinary Share. The RSUs vested for 5,000 shares on February 9, 2026, with 5,000 more vesting on each of March 15, 2026, June 15, 2026 and September 15, 2026. He also directly holds 133,334 Class A Ordinary Shares and indirectly 763,028 shares through King Regent Management Limited, over which he has voting and dispositive power while disclaiming beneficial ownership beyond his pecuniary interest.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chen Hung-Wen

(Last) (First) (Middle)

989 E HILLSDALE BLVD, SUITE 220

(Street)

FOSTER CITY CALIFORNIA 94404

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Apollomics Inc. [ APLM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Ordinary Shares	133,334	D
Class A Ordinary Shares	763,028	I	Through King Regent Management Limited(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	(2)	Class A Ordinary Shares	20,000	(3)	D

Explanation of Responses:

1. The reporting person is the sole director and shareholder of King Regent Management Limited and has voting and dispositive power over the shares held by King Regent Management Limited. Accordingly, Mr. Chen may be deemed to be the beneficial owner of such shares. Mr. Chen disclaims beneficial ownership of the securities held by King Regent Management Limited, except to the extent of his pecuniary interest therein.

2. The restricted stock units were vested with respect to 5,000 shares upon grant on February 9, 2026, with an additional 5,000 shares vesting on each of March 15, 2026, June 15, 2026 and September 15, 2026.

3. Each restricted stock unit represents a contingent right to receive one Class A Ordinary Share.

Remarks:

This Initial Statement of Beneficial Ownership is being filed in connection with the enactment of the Holding Foreign Insiders Accountable Act and the rules and regulations adopted in association therewith.

	/s/ Chen, Hung-Wen (Howard)	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Chen Hung-Wen’s Form 3 filing show for Apollomics (APLM)?

The Form 3 shows Chen Hung-Wen’s initial ownership in Apollomics, including direct shares, indirect shares through King Regent Management Limited, and restricted stock units that convert into Class A Ordinary Shares as they vest over specific 2026 dates.

How many Apollomics (APLM) restricted stock units does Chen Hung-Wen report?

He reports 20,000 restricted stock units, each representing one Class A Ordinary Share. These units vest in four equal 5,000‑share installments tied to dates in 2026, providing a structured equity-based compensation position over time.

What direct Class A share holdings does Chen Hung-Wen report in Apollomics (APLM)?

He reports directly holding 133,334 Class A Ordinary Shares. This direct position is separate from his restricted stock units and from additional shares held indirectly through King Regent Management Limited, over which he has voting and dispositive power.

What is King Regent Management Limited’s role in Apollomics (APLM) ownership?

King Regent Management Limited holds 763,028 Class A Ordinary Shares indirectly associated with Chen Hung-Wen. He is its sole director and shareholder with voting and dispositive power, but he formally disclaims beneficial ownership except for his pecuniary interest in those securities.

How do Chen Hung-Wen’s restricted stock units in Apollomics (APLM) vest?

The restricted stock units vested for 5,000 shares upon grant on February 9, 2026. Additional tranches of 5,000 shares vest on March 15, 2026, June 15, 2026 and September 15, 2026, gradually delivering Class A Ordinary Shares over that schedule.

Does the Apollomics (APLM) Form 3 show any insider buying or selling by Chen Hung-Wen?

No specific buying or selling transactions are shown. The entries are characterized as holdings, detailing his existing direct and indirect share positions and his restricted stock units, rather than recording new market purchases or sales of Apollomics shares.